Correct!
In Study GTC-205, LDL-C demonstrated mean LDL-C reduction from baseline at Week 4:†‡
atorvastatin 10 mg QD -38.5% (p<0.0001); atorvastatin 80 mg QD -56.3% (p<0.0001); LODALIS® 2.0 g BID + atorvastatin 10 mg QD -49.1% (p<0.0001). The decrease in LDL-C was greater after treatment with the combination atorvastatin-LODALIS® than after treatment with atorvastatin 10 mg alone (p=0.007), but not different from atorvastatin 80 mg alone (p=0.070).